Trial intelligence / Profile preview

OPERA: Omega-3 fatty acids for post-operative atrial fibrillation

NCT00970489Phase 3Completed

Sponsor
Brigham and Women's Hospital
Start
Aug 2010
Primary completion
May 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of omega-3 fatty acid in Atrial fibrillation (AFib), sponsored by Brigham and Women's Hospital. Started Aug 2010; status: completed.

02

Drugs

omega-3 fatty acid
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NCT00970489.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00970489.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call